165 related articles for article (PubMed ID: 11167684)
1. Should adjuvant radiotherapy be recommended following resection of regional lymph node metastases of malignant melanomas?
Fuhrmann D; Lippold A; Borrosch F; Ellwanger U; Garbe C; Suter L
Br J Dermatol; 2001 Jan; 144(1):66-70. PubMed ID: 11167684
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant irradiation for axillary metastases from malignant melanoma.
Ballo MT; Strom EA; Zagars GK; Bedikian AY; Prieto VG; Mansfield PF; Lee JE; Gershenwald JE; Ross MI
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):964-72. PubMed ID: 11958890
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant postoperative radiotherapy to the cervical lymph nodes in cutaneous melanoma: is there any benefit for high-risk patients?
Moncrieff MD; Martin R; O'Brien CJ; Shannon KF; Clark JR; Gao K; McCarthy WM; Thompson JF
Ann Surg Oncol; 2008 Nov; 15(11):3022-7. PubMed ID: 18958539
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant irradiation for cervical lymph node metastases from melanoma.
Ballo MT; Bonnen MD; Garden AS; Myers JN; Gershenwald JE; Zagars GK; Schechter NR; Morrison WH; Ross MI; Kian Ang K
Cancer; 2003 Apr; 97(7):1789-96. PubMed ID: 12655537
[TBL] [Abstract][Full Text] [Related]
6. A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.
Ballo MT; Zagars GK; Gershenwald JE; Lee JE; Mansfield PF; Kim KB; Camacho LH; Hwu P; Ross MI
Ann Surg Oncol; 2004 Dec; 11(12):1079-84. PubMed ID: 15576833
[TBL] [Abstract][Full Text] [Related]
7. The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma.
Agrawal S; Kane JM; Guadagnolo BA; Kraybill WG; Ballo MT
Cancer; 2009 Dec; 115(24):5836-44. PubMed ID: 19701906
[TBL] [Abstract][Full Text] [Related]
8. Clinical review of treatment outcomes and patterns of failure with adjuvant radiotherapy in node-positive malignant melanoma.
Keenan LG; O'Sullivan S; Glynn A; Higgins M; Flavin A; Brennan S
J Med Imaging Radiat Oncol; 2017 Apr; 61(2):258-262. PubMed ID: 27667733
[TBL] [Abstract][Full Text] [Related]
9. Combined-modality therapy for patients with regional nodal metastases from melanoma.
Ballo MT; Ross MI; Cormier JN; Myers JN; Lee JE; Gershenwald JE; Hwu P; Zagars GK
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):106-13. PubMed ID: 16182463
[TBL] [Abstract][Full Text] [Related]
10. Radiation therapy following lymph node dissection in melanoma patients: treatment, outcome and complications.
Bastiaannet E; Beukema JC; Hoekstra HJ
Cancer Treat Rev; 2005 Feb; 31(1):18-26. PubMed ID: 15707701
[TBL] [Abstract][Full Text] [Related]
11. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial.
Henderson MA; Burmeister BH; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
Lancet Oncol; 2015 Sep; 16(9):1049-1060. PubMed ID: 26206146
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant radiation therapy after axillary lymphadenectomy for metastatic melanoma: toxicity and local control.
Strom EA; Ross MI
Ann Surg Oncol; 1995 Sep; 2(5):445-9. PubMed ID: 7496841
[TBL] [Abstract][Full Text] [Related]
14. Radiation therapy for nodal disease in malignant melanoma.
Burmeister BH; Smithers BM; Poulsen M; McLeod GR; Bryant G; Tripcony L; Thorpe C
World J Surg; 1995; 19(3):369-71. PubMed ID: 7638990
[TBL] [Abstract][Full Text] [Related]
15. Regional control of melanoma neck node metastasis after selective neck dissection with or without adjuvant radiotherapy.
Hamming-Vrieze O; Balm AJ; Heemsbergen WD; Hooft van Huysduynen T; Rasch CR
Arch Otolaryngol Head Neck Surg; 2009 Aug; 135(8):795-800. PubMed ID: 19687401
[TBL] [Abstract][Full Text] [Related]
16. Ultrasonographic detection of regional lymph node metastases in patients with intermediate or thick malignant melanoma.
Brountzos EN; Panagiotou IE; Bafaloukos DI; Kelekis DA
Oncol Rep; 2003; 10(2):505-10. PubMed ID: 12579298
[TBL] [Abstract][Full Text] [Related]
17. Benefit of sentinel lymphadenectomy for patients with nonulcerated cutaneous melanomas in the Breslow range between 0.76 and 1 mm: a follow-up study of 148 patients.
Starz H; Balda BR
Int J Cancer; 2007 Aug; 121(3):689-93. PubMed ID: 17397029
[TBL] [Abstract][Full Text] [Related]
18. [Radiotherapy of malignant melanoma of the skin].
Suter L; Fuhrmann D
Praxis (Bern 1994); 2001 Mar; 90(10):397-402. PubMed ID: 11305185
[TBL] [Abstract][Full Text] [Related]
19. Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck.
Bonnen MD; Ballo MT; Myers JN; Garden AS; Diaz EM; Gershenwald JE; Morrison WH; Lee JE; Oswald MJ; Ross MI; Ang KK
Cancer; 2004 Jan; 100(2):383-9. PubMed ID: 14716775
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of Postoperative Radiotherapy Using Conventional Fractionation for Lymph Node Metastasis from Cutaneous Melanoma.
Kim YJ; Song SY; Kim W; Jeong SY; Choi W; Je HU; Lee JS; Choi EK
Anticancer Res; 2017 Aug; 37(8):4239-4246. PubMed ID: 28739713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
